Additionally, NAFLD correlated with the phosphorylation of pRB in the liver in different mouse models of obesity and diabetes (16, 61), altogether consistent with increased E2F1 activity in these conditions. Here, E2F1 is linked to metabolic dysfunction-associated steatotic liver disease.